Shrooms in the News Vol. 8: All the Guided Psilocybin Therapy Headlines Fit to Print

Just like a Norman Rockwell paperboy pedaling through anytown USA, here I am with the latest edition of your psilocybin therapy newspaper. Behold, your 8th installment of Shrooms in the News, a bimonthly roundup of what’s happening in the world of legal mushroom therapy.

Study Shows Psilocybin Slows Aging in Mice

A recent study found that psilocin, the active form of psilocybin, extended cellular lifespan. Psilocybin treatment also increased longevity in aged mice, suggesting it may act as a powerful anti-aging compound.

What’s In A Psilocybin Guide?

An article in Psychology Today highlights the role of the facilitator in psilocybin therapy. Though it devolves into a promotional piece, it provides a thoughtful and considered take on the relationship between patient and client. 

Magic Mushrooms Can Help Us Drink Less

In this small open-label study, all participants completed the treatment, and most showed meaningful reductions in heavy drinking and alcohol cravings, along with increased confidence in their ability to resist drinking. 

New Zealand Is Officially on the Legal Psilocybin Bandwagon

Down New Zealand way, Dr. Cameron Lacey, a psychiatrist, has been given the green light to prescribe psilocybin for depression.

Yale Study Seeks to Understand the Mechanism Behind Successful Outcomes with Psilocybin Therapy for Folks with OCD

This study looks at how psilocybin affects OCD symptoms and aims to uncover the brain mechanisms behind its potential healing effects. It’s actively recuiting participants if you fit the criteria an you’re so inclined.

Next
Next

Failure to Launch: How to Embrace an Underwhelming Mushroom Journey